NAVAMEDIC ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.9 NOK | +0.58% |
|
+2.65% | -4.90% |
| 06/05 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
| 30/04 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 56.72M | ||||||
| 728B | ||||||
| 603B | ||||||
| 360B | ||||||
| 332B | ||||||
| 279B |
- Stock Market
- Equities
- NAVA Stock
- Charts Navamedic ASA
- Sector Chart
